The role of apoptosis in hematologic malignancies and modulation of apoptosis as a new therapeutic approach

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 3-4, 1999, Pages 226-231

  Kliche, Kay Oliver ^a   Höffken, Klaus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Apoptosis; Chronic lymphocytic leukemia (CLL); Modulation of apoptosis; Myelodysplastic syndromes (MDS)

Indexed keywords

CASPASE; FLUDARABINE; METHYLPREDNISOLONE; PROTEIN BCL 2;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; LEUKEMOGENESIS; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT PLANNING;

APOPTOSIS; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, PROMYELOCYTIC, ACUTE; MYELODYSPLASTIC SYNDROMES;

EID: 0345561654     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050267     Document Type: Article

References (28)

1. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917
2. Bedi A, Barber JP, Bedi GC, el Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ, Kerbel RS (1995) BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents Impact of multicellular resistance on the survival of solid tumors, including micrometastases. Blood 86:1148
3. Bram S, Froussard P, Guichard M, Jasmin C, Augery Y, Sinoussi Barre F, Wray W (1980) Vitamin C preferential toxicity for malignant melanoma cells. Nature 284:629
4. Chandra J, Gilbreath J, Freireich E, Kliche KO, Andreeff M, Keating M, McConkey D (1997) Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood 90:3673
5. Chandra J, Niemer I, Gilbreath J, Kliche KO, Andreeff M, Freireich E, Keating M, McConkey D (1998) Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood 92:4220
6. Dai J, Weinberg R, Waxman S, Jing Y (1999) Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268
7. Delia D, Aiello A, Meroni L, Nicolini M, Reed JC, Pierotti MA (1997) Role of antioxidants and intracellular free radicals in retinamide-induced cell death. Carcinogenesis 18:943
8. Dietrich JB (1997) [Apoptosis and anti-apoptosis genes in the Bcl-2 family]. Arch Physiol Biochem 105:125
9. Farrow SN, Brown R, Mignotte B, Vayssiere JL (1996) New members of the Bcl-2 family and their protein partners Mitochondria and apoptosis. Curr Opin Genet Dev 6:45
10. Haendeler J, Zeiher AM, Dimmeler S (1996) Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol 317:407
11. Hannun YA (1997) Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845
12. Kidd VJ, Mignotte B, Vayssiere JL (1998) Proteolytic activities that mediate apoptosis Mitochondria and apoptosis. Annu Rev Physiol 60:533
13. Kliche KO, Andreeff M (1996) Hyperapoptosis as pathophysiologic basis of myelodysplastic syndromes (MDS). Blood 88:639
14. Kliche KO, Andreeff M (1997) High expression of phosphatidylserine (PS) in MDS, secondary AML (sAML) and normal progenitors: Comparison with primary AML (pAML). Blood 90:202
15. Kliche KO, Clement J, Kunert C, Fricke H, Höffken K (1998) Increased caspase activity in myelodysplastic syndromes and secondary acute myeloid leukemias. Blood 92:419
16. Kobayashi T, Ruan S, Clodi K, Kliche KO, Shiku H, Andreeff M, Zhang W (1998) Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents. Oncogene 16:1587
17. Kumar R, Mandal M, Ratzkin BJ, Liu N, Lipton A, Kumar R, Mendelsohn J (1996) NDF induces expression of a novel 46 kD protein in estrogen receptor positive breast cancer cells. Reduced expression of c-erbB2 gene product in human mammary carcinoma SK-BR-3 cells treated with interferon-gamma and tumor necrosis factor-alpha. J Cell Biochem 62:102
18. Lincz LF (1998) Deciphering the apoptotic pathway: all roads lead to death. Immunol Cell Biol 76:1
19. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807
20. Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808
21. Meterissian SH (1997) Apoptosis: its role in the progression of and chemotherapy for carcinoma. J Am Coll Surg 184:658
22. Nita ME, Nagawa H, Tominaga O, Tsuno N, Fujii S, Sasaki S, Fu CG, Takenoue T, Tsuruo T, Muto T (1998) 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer 78:986
23. Osorio LM, De Santiago A, Aguilar Santelises M, Mellstedt H, Jondal M (1997) CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Blood 89:2833
24. Pepper C, Hoy T, Bentley P (1998) Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance. Leuk Lymphoma 28:355
25. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments]. Blood 86:268
26. Sakagami H, Satoh K (1997) Modulating factors of radical intensity and cytotoxic activity of ascorbate (review). Anticancer Res 17:3513
27. Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251
28. Zhang K, Mack P, Wong KP (1998) Glutathione-related mechanisms in cellular resistance to anticancer drugs. Int J Oncol 12:871